Cited by 258Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record.

Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes

Bode, Bruce W, Steed, R Dennis, Davidson, Paul C·1996·Diabetes Care

Open this paper in CoChat — free account

Abstract

Objective To compare the incidence of severe hypoglycemia in patients crossed over from multiple daily injections (MDIs) of insulin to continuous subcutaneous insulin infusion (CSII). Research design and methods From a population of 225 patients using CSII, all patients who met the following selection criteria were included in the present study: 1) a minimum of 12 months on intensive therapy with MDIs before switching to CSII, and 2) a minimum of 12 months on CSII after crossover. Glycemic control and adverse event rates for the 1-year MDI control period were compared with those for the CSII therapy period. Results The incidence of severe hypoglycemia during MDI therapy declined from 138 to 22 events per 100 patient-years during the 1st year of CSII (P or = 8.0%, the change to CSII was associated with a significant reduction in HbA1c from baseline to year 1 (8.9 +/- 0.8 vs. 8.1 +/- 1.0%, P = 0.0004). The difference in diabetic ketoacidosis rates between the MDI year (14.6 events per 100 patient-years) and the CSII period (7.2 events per 100 patient-years) was not statistically significant. Conclusions CSII therapy was associated with a marked and sustained reduction in the rate of severe hypoglycemia without adversely affecting the level of glycemic control attained during MDI therapy. The more reproducible and flexible insulin delivery afforded by CSII was considered to be the major factor contributing to the improvement in severe hypoglycemia rates.

Integrity signals

Registry

Crossref · 10.2337/diacare.19.4.324

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 101–200 of 258

Cetoacidose diabética em adultos: atualização de uma complicação antiga
Barone, B., Rodacki, M., Cenci, M. C. P., Zajdenverg, L., Milech, A., & de Oliveira, J. E. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000900005 · Cited by 20
Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
Misso, M. L., Egberts, K. J., Page, M. J., O’Connor, D. A., & Shaw, J. E. (2010) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.623 · Cited by 18
Insulin Delivery Devices
Stewart, K. M., Wilson, M. F., & Rider, J. M. (2004) · Journal of Pharmacy Practice · doi:10.1177/0897190003261305 · Cited by 17
Lessons from Type 1 Diabetes for Understanding Natural History and Prevention of Autoimmune Disease
Simmons, K. M., & Michels, A. W. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.07.008 · Cited by 16
Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus
Kwai, N. C. G., Arnold, R., Poynten, A. M., Lin, C. S.-Y., Kiernan, M. C., & Krishnan, A. V. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2583 · Cited by 16
Hypoglycaemia: Its pathophysiology in insulin treated diabetes and hypoglycaemia unawareness
Heller, S. R. (2011) · The British Journal of Diabetes · doi:10.1177/1474651410397248 · Cited by 15
Sensor-augmented pump therapy – on the way to artificial pancreas
Schönauer, M., & Thomas, A. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)63002-5 · Cited by 15
Basal‐IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes
Messer, L. H., Campbell, K., Pyle, L. L., & Forlenza, G. P. (2020) · Diabetic Medicine · doi:10.1111/dme.14381 · Cited by 14
Uso de bomba de infusão subcutânea de insulina e suas indicações
Minicucci, W. J. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200022 · Cited by 14
Managing older adults with diabetes
Hainer, T. A. (2006) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2006.00136.x · Cited by 14
Hypoglycaemia and Counterregulation during Childhood
Matyka, K. A., Ford‐Adams, M., & Dunger, D. B. (2002) · Hormone Research in Paediatrics · doi:10.1159/000053322 · Cited by 14
Impact of therapeutic advances on hypoglycaemia in type 2 diabetes
Boyle, P. J., & Zrebiec, J. F. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.795 · Cited by 14
Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide
Tyagi, P., Koskinen, M., Mikkola, J. H., Sarkhel, S., Leino, L., Seth, A., Madalli, S., Will, S., HOWARD, V. G., Brant, H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030553 · Cited by 13
Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection
Franciosi, M., Maione, A., Pomili, B., Amoretti, R., Busetto, E., Capani, F., Bruttomesso, D., Bartolo, P. D., Girelli, A., Leonetti, F., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.02.012 · Cited by 13
The bourner lecture: Electrochemical power sources — an important contributor to modern health care
Holmes, C. F. (1997) · Journal of Power Sources · doi:10.1016/s0378-7753(96)02610-9 · Cited by 13
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia
Xu, S., Alexander, K., Bryant, W., Cohen, N., Craig, M. E., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes‐Walker, D. J., et al. (2015) · Internal Medicine Journal · doi:10.1111/imj.12619 · Cited by 13
Continuous Subcutaneous Insulin Infusion in Patients with Diabetes Mellitus
Schiel, R. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00038.x · Cited by 13
Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository
Song, C., Booth, G. L., Perkins, B. A., & Weisman, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002371 · Cited by 12
Tipos de insulinoterapia
de la Fuente, J. S., Berná, V. G., Piquero, J. M. F., Zanuy, M. Á. V., & López-Coterilla, A. H. D. T. (2008) · Revista Clínica Española · doi:10.1157/13115203 · Cited by 12
Basal Insulin Substitution with Glargine or Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Patients—A Randomized Controlled Trial
Bragd, J., von Döbeln, A., LINS, P.-E. S., Adamson, U., Bergström, J., & Oskarsson, P. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0062 · Cited by 12
Insulin Pump Therapy (Continuous Subcutaneous Insulin Infusion)
White, R. D. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.07.005 · Cited by 12
Efficacy of Insulin Pump Therapy: Mealtime Delivery is the Key Factor
Crawford, L. M., Sinha, R. N. P., O’Dell, R. M., & Comi, R. J. (2000) · Endocrine Practice · doi:10.4158/ep.6.3.239 · Cited by 12
Insulin pump therapy guidelines for China (July 2010)
Mu, Y., & Yin, S. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00174.x · Cited by 11
Insulin pumps use in Greece: Efficacy and safety data from 140 patients with type 1 diabetes mellitus
Somali, M., Paschou, S. Α., & Mouslech, Z. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108026 · Cited by 11
Age and A1C Are Important Clinical Predictors of Continuous Subcutaneous Insulin Infusion Efficacy in Type 1 Diabetic Patients
Lepore, G., Dodesini, A. R., Nosari, I., & Trevisan, R. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1834 · Cited by 11
Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes
Gao, G.-Q., Heng, X., WANG, Y.-L., Li, W., DONG, Q.-Y., LIANG, C.-G., Du, W., & LIU, X.-M. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1866 · Cited by 10
Treatment effects and satisfaction in diabetic patients changing from multiple daily insulin injections to CSII
Garmo, A., Pettersson‐Frank, B., & Ehrenberg, A. (2004) · Practical Diabetes · doi:10.1002/pdi.567 · Cited by 10
Insulin pump therapy for type 2 diabetes
Kirk, S. E. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0080-3 · Cited by 10
Metabolic control with insulin pump therapy: the Waikato experience.
Reda, E. S., Reitzenstein, A. V., & Dunn, P. J. (2007) · PubMed · Cited by 10
Future Developments in Insulin Pump Therapy
Fisher, L. K., & Halvorson, M. (2006) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721705285644 · Cited by 10
Cell therapies for type 1 diabetes mellitus
Shamblott, M. J., & Clark, G. O. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.3.269 · Cited by 10
Structural basis for regulation in gram-negative bacterial citrate synthases.
Duckworth, H. W., Anderson, D. H., Bell, A. W., Donald, L. J., Chu, A. L., & Brayer, G. D. (1987) · PubMed · Cited by 10
Persistent disparities in insulin pump uptake despite a universal pump programme for type 1 diabetes in Ontario, Canada
Soliman, Y., Everett, K., Shulman, R. M., Austin, P. C., Lipscombe, L. L., Booth, G. L., & Weisman, A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15799 · Cited by 9
Evaluación de la utilización de las prestaciones específicas de los sistemas de infusión subcutánea de insulina y su relación con el control metabólico en pacientes con diabetes tipo 1
Quirós, C., Patrascioiu, I., Giménez, M., Vinagre, I., Vidal, M., Jansà, M., & Conget, I. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.01.003 · Cited by 9
Insulinization: A promising strategy for the treatment of type 2 diabetes mellitus
Guo, L., Xu, Y., XIANXIANG, Z., YONG, L., Liu, W., & BING, C. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1300 · Cited by 9
Use of New Technologies for Monitoring and Treating Diabetes in Pregnancy
Yogev, Y., & Hod, M. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.03.005 · Cited by 9
Insulin aspart: promising early results borne out in clinical practice
Heller, S. R., Kurtzhals, P., Verge, D., & Lindholm, A. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.2.183 · Cited by 9
2: Recent advances in therapy of diabetes
Couper, J., & Prins, J. B. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05628.x · Cited by 9
Continuous Subcutaneous Insulin Infusion
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s116 · Cited by 9
Continuous Subcutaneous Insulin Infusion
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s125 · Cited by 9
Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland
Cypryk, K., Wender-Ożegowska, E., Cyganek, K., Sieradzki, J., Skoczylas, K., Chen, X., Cordero, T. L., Shin, J., & Cohen, O. (2023) · Acta Diabetologica · doi:10.1007/s00592-022-02020-9 · Cited by 8
Evolving Approaches to Intensive Insulin Therapy in Type 1 Diabetes: Multiple Daily Injections, Insulin Pumps and New Methods of Monitoring
Stephens, E., & Riddle, M. C. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1027345927676 · Cited by 8
Achieving goal glycosylated hemoglobin levels in type 2 diabetes mellitus: Practical strategies for success with insulin therapy
Garg, S. K., & Ulrich, H. (2006) · Insulin · doi:10.1016/s1557-0843(06)80020-5 · Cited by 7
Feasibility of Overnight Closed-Loop Control Based on Hourly Blood Glucose Measurements
Patte, C., Pleus, S., Galley, P. J., Weinert, S., Haug, C., & Freckmann, G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600422 · Cited by 7
Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes
Quirós, C., Patrascioiu, I., Giménez, M., Vinagre, I., Vidal, M., Jansà, M., & Conget, I. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.06.003 · Cited by 7
Continuous subcutaneous insulin infusion: short-term benefits apparent, long-term benefits speculative
Hammond, P. J. (2004) · The British Journal of Diabetes · doi:10.1177/14746514040040020701 · Cited by 7
Modelling the effect of CSII on the control of glucose concentration in type 1 diabetes
Nilam, N., Alexander, M. E., Mathur, R., Moghadas, S. M., & Shivakumar, P. N. (2006) · Applied Mathematics and Computation · doi:10.1016/j.amc.2006.09.105 · Cited by 7
The state of insulin pump therapy: 2002
Plodkowski, R. A., & Edelman, S. V. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00006 · Cited by 7
Long-term use of continuous subcutaneous insulin infusion
Pickup, J. C. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(06)70008-0 · Cited by 6
An overview of insulin pump therapy: appropriate use of an expensive resource
Brown, V. (2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872290 · Cited by 6
An Audit of Clinical Practice in a Single Centre in Kuwait: Management of Children on Continuous Subcutaneous Insulin Infusion and Cardiovascular Risk Factors Screening
Omar, D., Al-Sanae, H., Alkhawari, M., Abdul-Rasoul, M. M., Rahme, Z., Al-Refaei, F. H., Behbehani, K., & Shaltout, A. (2017) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401711010019 · Cited by 6
Protocol for Outpatient Screening and Initiation of Continuous Subcutaneous Insulin Infusion Therapy: Impact on Cost and Quality
SANFIELD, J. A., Hegstad, M., & Hanna, R. (2002) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572170202800414 · Cited by 6
How technology has changed diabetes management and what it has failed to achieve
Ratheau, L., Jeandidier, N., Moreau, F., Sigrist, S., & Pinget, M. (2011) · Diabetes & Metabolism · doi:10.1016/s1262-3636(11)70967-3 · Cited by 7
External and implantable insulin pumps: current place in the treatment of diabetes
Sélam, J. L. (2000) · Springer eBooks · doi:10.1007/978-94-011-4118-5_12 · Cited by 6
Predictive Low Glucose Suspend Algorithm in Real Life: A Five-Year Follow-Up Retrospective Analysis
Tubili, C., Pollakova, D., Nardone, M. R., & Folco, U. D. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820952107 · Cited by 5
Initiating insulin therapy in children and adolescents with type 1 diabetes mellitus
Wangnoo, S. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.155406 · Cited by 8
Acute complications of insulin pump therapy
Guerci, B. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(06)70009-2 · Cited by 6
Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Insulin Injection Therapy in Type 1 Diabetes Mellitus: 18-Month Follow-Up
Hissa, M. N., Hissa, A. S. R., de Bruin, V. M. S., & Fredrickson, L. P. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.411 · Cited by 5
Tratamento do diabetes mellitus tipo 1 com bomba de infusão subcutânea contínua de insulina e insulina lispro
Hissa, M. N., Hissa, A. S. R., & de Bruin, V. M. S. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000500013 · Cited by 5
The Utility of Insulin Glargine in the Treatment of Diabetes Mellitus
Stroup, J. S., Kane, M. P., Busch, R. S., Bakst, G., & Hamilton, R. A. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.8.736.36064 · Cited by 5
Is Insulin Pump Treatment Justifiable?
Pickup, J. C. (2001) · Wiley eBooks · doi:10.1002/9780470757109.ch13 · Cited by 5
Good Long-Term Quality of Life Without Diabetic Complications With 20 Years of Continuous Subcutaneous Insulin Infusion Therapy in a Brittle Diabetic Elderly Patient
Kamoi, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.402 · Cited by 5
Diabetic ketoacidosis in childhood and adolescence
Silink, M. (2011) · doi:10.1093/med/9780199235292.003.1473 · Cited by 4
Continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: Do the benefits outweigh the risks?
Toth, G. H. (2005) · Paediatrics & Child Health · doi:10.1093/pch/10.1.28 · Cited by 4
Reducing glucose variability with continuous subcutaneous insulin infusion is associated with reversal of axonal dysfunction in type 1 diabetes mellitus
Kamel, J. T., Loh, M., Cook, M. J., MacIsaac, R. J., & Roberts, L. J. (2019) · Muscle & Nerve · doi:10.1002/mus.26738 · Cited by 4
The effect of carbohydrate counting on metabolic control in patients with type 1 diabetes mellitus
Abacı, A., Ataş, A., Ünüvar, T., Böber, E., & Büyükgebiz, A. (2009) · Gulhane Medical Journal · Cited by 4
Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion
Zöllner, Y. F., Ziegler, R., Stueve, M., Krumreich, J., & Schauf, M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633720 · Cited by 3
Rapid and ultra-rapid insulin in glycemic control
Borri, A., Panunzi, S., & Gaetano, A. D. (2019) · Conference proceedings/Conference proceedings - IEEE International Conference on Systems, Man, and Cybernetics · doi:10.1109/smc.2019.8914559 · Cited by 3
Case Files of the Harvard Medical Toxicology Fellowship at Children’s Hospital Boston: An Insulin Overdose
Skolnik, A. B., & Ewald, M. B. (2010) · Journal of Medical Toxicology · doi:10.1007/s13181-010-0110-x · Cited by 3
Bombas de insulina
Vaquero, P. M., Martínez, A. F., & Pallardo, L. F. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74400-0 · Cited by 3
Counterregulatory responses in CSII
Fanelli, C. G., & Rossetti, P. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(06)70010-9 · Cited by 3
Comparação entre a bomba de infusão de insulina subcutânea e o esquema de múltiplas doses de insulina em adolescentes com diabetes melito do tipo 1 da rede pública de saúde na abordagem da hipoglicemia grave
Gabbay, M. A. L., & Dib, S. A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000700022 · Cited by 3
Leitlinien Insulinpumpentherapie bei Kindern und Erwachsenen (Für den Ausschuss Insulinpumpentherapie der Österreichischen Diabetesgesellschaft)
Stadler, M., Zlamal-Fortunat, S., Schütz-Fuhrmann, I., Rami-Merhar, B. M., Schober, E., Kautzky‐Willer, A., Weitgasser, R., Prager, R., & Bischof, M. G. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0287-x · Cited by 3
Hypoglycemia in Type 1 Diabetes
Amiel, S. A., & Matyka, K. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_18 · Cited by 3
Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, Canada
Soliman, Y., Everett, K., Shulman, R. M., Austin, P. C., Lipscombe, L. L., Booth, G. L., & Weisman, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16547 · Cited by 2
Therapeutic Modelling of Type 1 Diabetes
Nilam, N., Seyed, M., & Pappur, N. (2011) · InTech eBooks · doi:10.5772/21919 · Cited by 2
The role of practice nurses in the delivery of insulin pump therapy
Morrison, G., & Weston, P. J. (2013) · Practice Nursing · doi:10.12968/pnur.2013.24.2.72 · Cited by 2
Atlas of Diabetes Mellitus
Scobie, I. N., & Hopkins, D. L. (2023) · CRC Press eBooks · doi:10.1201/9781003342700 · Cited by 2
Continuous subcutaneous insulin infusion: experience from a large specialist service
Chellamuthu, P., Lawrence, I., Kitchener, D. L., McNally, P. G., Gregory, R., Jackson, S., Kong, M., Jarvis, J., & Davies, M. J. (2009) · Practical Diabetes · doi:10.1002/pdi.1337 · Cited by 2
Estudio longitudinal del impacto del tratamiento con infusores de insulina en variables psicológicas, la calidad de vida el control glucémico de pacientes con diabetes mellitus tipo 1
Ortiz, M. T. A., de Adana, M. S. R., Carreira, M., Dominguez-Lopez, M.-E., Machado, A., González-Molero, I., Caballero, F. F., de la Higuera, M., González‐Romero, S., Sánchez, I. S. G., et al. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)62008-x · Cited by 2
Insulin pump therapy
Rowe, R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.0180s4004.x · Cited by 2
Aktueller Stand der klassischen Insulinpumpentherapie
Siegmund, T., & Thomas, A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0205-y · Cited by 2
Objectives and methods of the ORCHESTRA FOUNDATION Registry study: a multicenter observational study of the use of insulin pump therapy in pregnant women with type 1 diabetes mellitus in Poland.
Sieradzki, J., Cyganek, K., Cypryk, K., Wender-Ożegowska, E., Skoczylas, K., Runzis, S., & Shin, J. H. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0009 · Cited by 2
Hypoglycemia in Type 1 Diabetes
Amiel, S. A. (2007) · CRC Press eBooks · doi:10.3109/9781420016512-3 · Cited by 2
Therapy of Type 1 Diabetes Mellitus
Cohan, P., & Peters, A. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_43 · Cited by 2
Introduction to Diabetes
Sheehan, P. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-168-8_1 · Cited by 2
Nuevos abordajes terapéuticos de la diabetes mellitus tipo 1
Acosta, D. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74617-3 · Cited by 2
Nocturnal Hypoglycaemia
Chow, E., & Heller, S. R. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch5 · Cited by 2
Introduction to Diabetes
Sheehan, P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-075-1_1 · Cited by 2
Therapy of Type 1 Diabetes Mellitus
Omura, E., Cohan, P., & Peters, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_43-2 · Cited by 1
Evaluación de la seguridad de los catéteres de teflón en pacientes diabéticos tipo 1 tratados con infusión subcutánea continua de insulina (ISCI) mediante la determinación de la cetonemia capilar
Ampudia‐Blasco, F. J., Parramón, M., Gabaldón, J., Sanz, J., Catalá, M., & Carmena, Y. R. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71071-3 · Cited by 1
Impact of Intensive Therapy With Continuous Subcutaneous Insulin Infusion on Quality of Life in Patients With Type 1 Diabetes
Ortiz, M. T. A., Díaz, F. F. C., Romero, A. M., Navas, M. S. R. D. A., Domínguez‐López, M., Gonzalo‐Marín, M., Tapia, M. J., Hernández, S. V., González‐Romero, S., Rojo‐Martínez, G., et al. (2010) · Journal of Applied Biobehavioral Research · doi:10.1111/j.1751-9861.2010.00049.x · Cited by 1
Wybrane aspekty leczenia dorosłych chorych na cukrzycę typu 1 za pomocą osobistej pompy insulinowej
Gawrecki, A., Duda‐Sobczak, A., Zozulińska‐Ziółkiewicz, D., & Wierusz‐Wysocka, B. (2011) · Via Medica Journals · Cited by 1
Möglichkeiten moderner Diabetestechnologie
Thomas, A. (2018) · Diabetes aktuell · doi:10.1055/a-0805-2727 · Cited by 1
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_19 · Cited by 1
Glycemic control and weight outcomes after initiation of continuous subcutaneous insulin infusion therapy
Esteves, C., Belo, S., Neves, M. C., Arteiro, C., & Carvalho, D. M. (2015) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2015.02.001 · Cited by 1
Ergebnisse eines Registers zur Insulinpumpentherapie in Deutschland
(AGDT), A. D. T., Quester, W., Reichel, A., & Henrichs, H. R. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1125-0 · Cited by 1
Comparison of Insulin Pump and Multiple Daily Injection Regimens in Type 1 Diabetic Patients
Bin-Abbas, B. S., Al-Fares, A., Sakati, N., & Al-Ashwal, A. A. (2006) · Current Pediatric Research · Cited by 1
Therapie mit Insulinpumpen
Berger, M., & Jörgens, V. (2001) · Springer eBooks · doi:10.1007/978-3-642-87912-8_13 · Cited by 1
Insulin settings and their association with time in range in patients with type 1 diabetes users of predictive low glucose suspend (PLGS) augmented insulin pumps in Santiago, Chile
Grassi, B. A., Caramés, B., Plaza‐Plaza, J. C., Onetto, M. T., Moreno, S., Sandoval, T., Tapia, N., Salas, F. M., & Revello, A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108262 · Cited by 1

Authors: Bode, B. W., Steed, R. D., & Davidson, P. C.
Affiliations: Atlanta Diabetes Associates (US)
ORCID: Bode, Bruce W
Steed, R Dennis
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 1996-04-01
Volume: 19
Issue: 4
Pages: 324-327
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.19.4.324
OpenAlex: W1989943003
Cited by: 257
References: 0
Citations by year: 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 7 · 2019: 2 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 9
FWCI: 2.62
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: severe hypoglycemia, insulin pump therapy, type 1 diabetes, multiple daily insulin injections, insulin delivery, glycemic control, HbA1c, diabetic ketoacidosis, intensive insulin therapy
MeSH terms: Adult, Algorithms, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Insulin Infusion Systems, Male, Time Factors, Blood Glucose Self-Monitoring, Incidence, Diabetic Ketoacidosis, Patient Selection, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks